Abstract:Ovalbumin (OVA), a commonly consumed food protein, can cause severe allergies and intestinal immune disorders. L-Theanine (LTA) and epigallocatechin gallate (EGCG) regulate intestinal immunity. However, it is unclear whether an LTA and EGCG combined intervention can alleviate OVA allergy (OVA-A) by modulating intestinal-specific immunity, and it is unknown whether there is a synergistic effect between LTA and EGCG. Therefore, we treated BALB/c OVA-sensitized mice with LTA, EGCG, or a combination of both (LTA + EGCG) to investigate the effects of LTA and EGCG on intestinal-specific immunity regulation and underlying mechanisms. Female mice were intraperitoneally injected with OVA to establish OVA-sensitive mouse models. MLEO LTA + EGCG (20 mg kg-1 d-1 LTA + 80 mg kg-1 d-1 EGCG) and HLEO (30 mg kg-1 d-1 LTA + 120 mg kg-1 d-1 EGCG) exerted more beneficial effects on alleviating OVA-A (weight gain, allergy score, jejunum structure, mast cell [MC] degranulation, thymus and spleen indices) than LTA or EGCG alone (p < 0.01). Based on the alleviation of OVA-A by LTA + EGCG, we selected MLEO mice for 16S rDNA, flow cytometry, and western blot analyses. The 16S rDNA results showed that MLEO increased the abundance of Lactobacillaceae, Lachnospiraceae, and Ruminococcaceae, and decreased that of Helicobacteraceae (p < 0.01). The flow cytometry and western blotting results indicated that MLEO reduced the number of dendritic cells available to capture OVA, thereby lowering the Th2 immune response and decreasing the IL-4 and IL-13 levels. Meanwhile, the attenuation of the Th2 immune response inhibits the cross-linking of OVA and FcεRI, thus reducing MC degranulation and decreasing the serum HIS and mMCPT-1 levels through the FcεRI/Btk/PLCγ signaling pathway. LTA + EGCG also inhibits the Th2 immune response through the FcεRI/Lyn/Syk/PI3K/AKT signaling pathway and decreases the serum IL-4 and IL-13 levels. Notably, LTA + EGCG promotes the Treg and Th1 immune responses and inhibits the Th17 immune response, altering the levels of the corresponding cytokines. Therefore, LTA + EGCG can synergistically alleviate OVA-A by regulating intestinal immunity through MC degranulation inhibition.

Laccase/caffeic Acid-Catalyzed Crosslinking Coupled with Galactomannan Alters the Conformational Structure of Ovalbumin and Alleviates Th2-mediated Allergic Asthma

Enhanced Immunomodulatory Properties of Ovalbumin Through Transglutaminase and Tyrosinase/caffeic Acid-Catalyzed Crosslinking Plus Galactomannan Conjugation Alleviates Allergic Asthma

Synergistic effects of L-theanine and epigallocatechin gallate in alleviating ovalbumin allergy by regulating intestinal immunity through inhibition of mast cell degranulation

Different Polyphenols on Cold Plasma-Induced Covalent Ovalbumin-Polyphenols Conjugates and Affecting the Antigenicity of OVA and Its Functionalities

Effect of Glycation Derived from Α-Dicarbonyl Compounds on the in Vitro Digestibility of Ovalbumin: Tracing of Advanced Glycation End-Products and Immuno-Active Peptides

Haemolytic activities and adjuvant effect of Astragalus membranaceus saponins (AMS) on the immune responses to ovalbumin in mice.

A recombinant protein rLZ-8, originally extracted from Ganoderma lucidum, ameliorates OVA-induced lung inflammation by regulating Th17/Treg balance

The effects of neutralizing anti-murine interleukin-17A monoclonal antibody on ozone-induced inflammation and glucocorticoids insensitivity in a murine model of asthma

Induction of Immune Tolerance in Asthmatic Mice by Vaccination with DNA Encoding an Allergen-Cytotoxic T Lymphocyte-Associated Antigen 4 Combination.

Lactobacillus fermentum CECT5716 Alleviates the Inflammatory Response in Asthma by Regulating TLR2/TLR4 Expression

Antigenicity Elimination of Ovalbumin by Cold Plasma-Induced Covalent Binding with Gallic Acid

Novel Polysaccharide Adjuvant from the Roots of Actinidia Eriantha with Dual Th1 and Th2 Potentiating Activity.

Lentiviral vector-mediated delivery of lysophosphatidylcholine acyltransferase 1 attenuates airway inflammation in ovalbumin-induced allergic asthmatic mice.

Molecular structure, IgE binding capacity and gut microbiota of ovalbumin conjugated to fructose and galactose:A comparative study

Lactoferrin Ameliorates Ovalbumin-Induced Asthma in Mice through Reducing Dendritic-Cell-Derived Th2 Cell Responses

Ganoderic Acid A Alleviates OVA-Induced Asthma in Mice

Synthesized OVA323-339MAP Octamers Mitigate OVA-induced Airway Inflammation by Regulating Foxp3 T Regulatory Cells

Potential Therapy of Fc-Antigen Combination-Encoding Dna Vaccination in Mouse Allergic Airway Inflammation

Research advance of non-thermal processing technologies on ovalbumin properties: The gelation, foaming, emulsification, allergenicity, immunoregulation and its delivery system application

Amelioration of Ovalbumin Induced Allergic Symptoms in Balb/C Mice by Potentially Probiotic Strains of Lactobacilli

Impact of antigen loading in tolerogenic nanoparticles to mitigate Th2-mediated allergic lung inflammation